Market Intelligence Ecosystem
https://www.youtube.com/watch?v=Mzpw87FqOBE Key highlights from Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY22 Earnings Concall Management Update: GLENMARK stated the India business continues to outperform
https://www.youtube.com/watch?v=iqM668J91yY Key highlights from Sequent Scientific Limited (SEQUENT) Q3 FY22 Earnings Concall Management Update: SEQUENT saw significant improvement in the API order
https://www.youtube.com/watch?v=E7EoiAKzMn0 Key highlights from Divi's Laboratories Ltd (DIVISLAB) Q3 FY22 Earnings Concall Management Update: The company capitalized INR196 crores in 3Q22 and
Apollo Hospitals Enterprise Limited (NSE: APOLLOHOSP) Q3 FY22 Earnings Concall dated Feb. 12, 2022 Corporate Participants: Mayank Vaswani -- Investor Relations Suneeta Reddy -- Managing Director Dr.
Divi's Laboratories Ltd (NSE: DIVISLAB) Q3 FY22 Earnings Concall dated Feb. 11, 2022 Corporate Participants: M. Satish Choudhury -- Company Secretary and Compliance Officer
Piramal Enterprises Ltd (NSE : PEL) Q3 FY22 Earnings Concall dated Feb. 10, 2022, Corporate Participants: Hitesh Dhaddha -- Chief Investor Relations
https://www.youtube.com/watch?v=q_lILVipT-E Key highlights from Dr Lal PathLabs Ltd (LALPATHLAB) Q3 FY22 Earnings Concall Management Update: The company is enhancing access of its
https://www.youtube.com/watch?v=Wh0LRTM3LTg Key highlights from Piramal Enterprises Ltd (PEL) Q3 FY22 Earnings Concall Management Update: In financial service, PEL said it plans to
Aurobindo Pharma Limited (NSE :AUROPHARMA) Q3 2022 Earnings Concall Feb. 10, 2022, Corporate Participants: Arvind Bothra -- Investor Relations Department Santhanam Subramanian
Cadila Healthcare Limited (NSE:CADILAHC) Q3 FY22 Earnings Concall dated Feb. 03, 2022 Corporate Participants: Ganesh Nayak -- Executive Sharvil P. Patel --
The estimated size of the hospital market in India was ₹4,270 billion in the fiscal year 2020, representing an annual growth of
https://www.youtube.com/watch?v=VEV5IjVrTNI Key highlights from Jubilant Ingrevia Ltd (JUBLINGREA) Q3 FY22 Earnings Concall Management Update: JUBLINGREA commented that with its capex plans shaping
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY22 Earnings Concall dated Jan. 31, 2022 Corporate Participants: Nimish Desai -- Head of Investor Relations Dilip
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a growth of
The pharma giant Cipla's net profit rose 7.57% year-on-year (YoY) to Rs 712 crore for Q2 FY22. Cipla market research report covers
Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY22 Earnings Concall dated Jan. 25, 2022 Corporate Participants: Sudhir Menon -- Executive Director and Chief Financial Officer
Cipla Limited (NSE:CIPLA) Q3 FY22 Earnings Concall dated Jan. 25, 2022 Corporate Participants: Naveen Bansal -- Investor Relations Kedar Upadhye -- Global
Gland Pharma Limited (NSE:GLAND) Q3 FY22 Earnings Concall dated Jan. 21, 2022 Corporate participants: Sumanta Bajpayee -- Vice President- Investor Relations Srinivas
SBI LIFE INSURANCE CO LTD (NSE:SBILIFE) Q3 FY22 Earnings Concall dated Jan. 21, 2022 Corporate Participants: Mahesh Kumar Sharma -- Managing Director and
Biocon Limited (NSE:BIOCON) Q3 FY22 Earnings Concall dated Jan. 20, 2022 Corporate participants: Aishwarya Sitharam -- Head of Investor Relations Kiran Mazumdar
ICICI Lombard General Insurance Company Limited (NSE:ICICIGI) Q3 FY22 Earnings Concall dated Jan. 19, 2022 Corporate Participants: Bhargav Dasgupta -- Managing Director